| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 04/15/1999 | CA2305786A1 Use of neuronal and lymphocytic potassium canal inhibitors for treating neurological diseases of immune origin |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0605501B1 Method and compositions for the treatment of cerebral palsy |
| 04/14/1999 | EP0584285B1 Treatment of schizophrenia by cholinesterase inhibitors |
| 04/08/1999 | WO1999016741A2 Lipophilic diesters of chelating agents |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/07/1999 | EP0647266B1 D-enzyme compositions and methods of their use |
| 04/07/1999 | CN1213307A Novel substituted imidazolium compounds |
| 04/07/1999 | CN1213303A Method of increasing sphincter competence |
| 04/06/1999 | US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 04/01/1999 | WO1999015159A2 Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| 04/01/1999 | WO1999003878A3 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 04/01/1999 | WO1999003826A3 Metalloproteinase inhibitors |
| 04/01/1999 | WO1999002497A3 Pyridine derivatives |
| 04/01/1999 | CA2304505A1 Methods for increasing apoe levels for the treatment of neurodegenerative disease |
| 03/31/1999 | EP0904384A2 Tyrosine-phosphatase-related protein |
| 03/31/1999 | EP0904284A1 6-substituted amino-4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as cysteine protease inhibitors |
| 03/31/1999 | EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 03/25/1999 | WO1999014346A2 SENSE mRNA THERAPY |
| 03/25/1999 | WO1999014340A1 Human prl-1 phosphatase |
| 03/25/1999 | WO1999014197A1 Substituted isoquinolines as anticonvulsivants |
| 03/25/1999 | WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/25/1999 | CA2304982A1 Sense mrna therapy |
| 03/25/1999 | CA2303777A1 Substituted isoquinolines as anticonvulsivants |
| 03/25/1999 | CA2303227A1 Human prl-1 phosphatase |
| 03/24/1999 | EP0902680A1 Reparation and prevention of fibrotic lesions |
| 03/23/1999 | US5885986 Cleaving, n-alkylating and reducing the intermediate formed by reacting an oxazolyl and thiazolylimidazobenzo and thienodiazepine derivatives with amine compounds; used as anxiolytic and anticonvulsant or sedative-hypnotic agents |
| 03/23/1999 | CA1340458C 1, 2, 3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists |
| 03/18/1999 | WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 03/18/1999 | WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 03/18/1999 | WO1998056909A3 Secreted proteins and polynucleotides encoding them |
| 03/18/1999 | CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 03/18/1999 | CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 03/17/1999 | EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell |
| 03/17/1999 | EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines |
| 03/11/1999 | WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/11/1999 | WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 03/11/1999 | CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 03/11/1999 | CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 03/10/1999 | EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/10/1999 | EP0900569A2 Therapeutic agent for herniated intervertebral disc |
| 03/10/1999 | EP0900080A1 Novel indole and benzothiazole derivatives |
| 03/09/1999 | US5880160 Antiproliferative, antineoplastic, antiinflammatory and muscle relaxant activities |
| 03/04/1999 | WO1999010378A1 Pompilid wasp-derived neuropeptides |
| 03/04/1999 | WO1999010347A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
| 02/25/1999 | WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | WO1999008708A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | WO1999008678A1 Heterocyclic vinylethers against neurological disorders |
| 02/25/1999 | CA2299291A1 Method and food product for increasing muscle protein and reducing fat in animals |
| 02/25/1999 | CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/24/1999 | EP0897980A2 CXCR4B: A human splice variant of CXCR4 chemokine receptor |
| 02/24/1999 | CN1209132A Macrocyclic compounds made from suboxide units |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/18/1999 | WO1999007707A1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h//2,3/BENZODIAZEPINE DERIVATIVES, AS AMPA/KAINATE RECEPTOR INHIBITORS |
| 02/18/1999 | CA2300302A1 8-substituted-9h-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as ampa/kainate receptor inhibitors |
| 02/17/1999 | CN1208033A Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities |
| 02/16/1999 | US5872118 Relaxation of skeletal muscle in spastic, hypertonic and hyperkinetic conditions |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006408A1 New 2,3-benzodiazepine derivatives |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/10/1999 | EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/09/1999 | US5869492 Condensed thiazole derivatives, having 5-HT receptor affinity |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/03/1999 | EP0894136A1 Method of treating muscular disorders |
| 02/03/1999 | EP0893951A1 METHODS OF MODULATING RADICAL FORMATION BY MUTANT CuZnSOD ENZYMES |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/03/1999 | CN1041931C [1,2,4] trizolo [4,3,-a] quinoxaline compounds, their preparation and use |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0796243B1 Diaminocyclobutene-3,4-diones |
| 01/26/1999 | US5863916 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002497A2 Pyridine derivatives |
| 01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 01/20/1999 | CN1041720C Bicyclic amide derivatives, its prepn. method, medicinal compsns. and medical application |
| 01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001428A1 Hydrazine derivatives |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2295062A1 Hydrazine derivatives |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0889731A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 01/13/1999 | EP0889730A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000115A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases |